Address : Bala Plz, Bala Cynwyd, Pennsylvania 19004, United States
Phone Number : +1 (617) 622-4003
Industries : Biotechnology
Website : larimartx.com
Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company's lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich's ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.
Employees Total : 50
Revenue (Yearly) : 2M
Total Funding : 52.4M
Latest Funding : 3.4M
Public Company : Yes
Trade Symbol : LRMR
Trade Exchange : Nasdaq
Market Cap : 2M
Founded in : 2016
Linkedin : larimar-therapeutics
Email Providers : Mimecast
Email Providers : Outlook
Hosting : GoDaddy Hosting
Domain Name Services : Route 53
Tech : Microsoft Office 365
Hosting : Amazon AWS
Last Updated : 2023-11-22
Director, Regulatory Affairs
Bala Cynwyd, Pennsylvania, United States
Posted at : 2023-11-19
Clinical Trial Associate (CTA)
Bala Cynwyd, Pennsylvania, United States
Posted at : 2023-11-19
Sr. Manager, Regulatory Affairs
Bala Cynwyd, Pennsylvania, United States
Posted at : 2023-11-19
Clinical Trial Associate (CTA)
Bala Cynwyd, Pennsylvania, United States
Posted at : 2023-11-19
EbixCash Financial Technologies Mumbai, Maharashtra, India Information Technology & Services |
Welingkar Institute of Management Mumbai, Maharashtra, India Education Management |
Nearex Technologies Singapore Information Technology & Services |
EVOLVE MEDICAL EQUIPMENT Medical Devices |
Chesa Dental Care Services Bengaluru, Karnataka, India Medical Devices |
GRENKE Australia Financial Services |